BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 3 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2024. The put-call ratio across all filers is - and the average weighting 5.6%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $92,446,000 | 56.70% |
| Knoll Capital Management, LLC | 749,815 | $32,834,000 | 26.88% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,672,950 | $73,258,000 | 15.76% |
| VHCP Management II, LLC | 962,903 | $42,166,000 | 13.29% |
| Broadfin Capital, LLC | 676,879 | $29,641,000 | 6.45% |
| Foresite Capital Management IV, LLC | 429,690 | $18,816,000 | 5.32% |
| Aisling Capital Management LP | 274,513 | $12,021,000 | 5.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,001,410 | $43,852,000 | 4.31% |
| ARS Investment Partners, LLC | 544,223 | $23,832,000 | 4.01% |
| ACUTA CAPITAL PARTNERS, LLC | 255,000 | $11,166,000 | 3.97% |